Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)


Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Analysis:

1. The market size of the Endoscopic Retrograde Cholangiopancreatography (ERCP) industry is projected to reach USD 2.27 billion by 2028, with an estimated value of USD 1.54 billion in 2023. This growth is attributed to a compound annual growth rate (CAGR) of 7.97% during the forecast period of 2023–2028. However, the COVID-19 pandemic had a significant impact on the market, leading to the cancellation of elective procedures, including endoscopy and other surgical interventions. The risk of disease transmission and the need for close physical proximity during endoscopic procedures posed challenges for healthcare providers. Despite these setbacks, the market has shown signs of recovery in recent years, driven by the increasing demand for minimally invasive endoscopic procedures.

2. The forecasted growth of the studied market is supported by several factors. Firstly, there is a rising incidence of pancreatic cancer, which necessitates the use of ERCP for early detection and treatment. According to the American Cancer Society, it is estimated that around 41,210 new cases of liver cancer will be diagnosed in the United States, with hepatocellular carcinoma and cholangiocarcinoma being the most common types. This high burden of liver cancer is expected to drive the demand for endoscopic retrograde cholangiopancreatography as a means of detecting and managing these malignancies. Additionally, the preference for minimally invasive surgeries is increasing among patients, leading to a higher demand for ERCP procedures. Furthermore, advancements in technology and devices used in ERCP contribute to the market’s growth potential.

3. The introduction of minimally invasive surgical techniques has played a crucial role in expanding the patient pool seeking ERCP operations. This trend is expected to continue in the coming years, further fueling the growth of the industry. The COVID-19 pandemic caused a temporary decline in ERCP case volumes, as reported in a study published in the Endoscopy International Journal. However, as the market recovers, the demand for minimally invasive endoscopic procedures is expected to remain stable. With the increasing prevalence of pancreatic cancer and the advantages offered by minimally invasive surgeries, the market for endoscopic retrograde cholangiopancreatography is poised for growth during the forecast period.

Get the free sample report of the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

Comments

Popular Posts

Aviation Industry Set to Soar: Market to Hit USD 395.76 Billion by 2030 Amid Stable Growth

Recreational Boating Market Set to Reach USD 36.82 Billion by 2030: Key Growth Drivers and Trends

Kuwait Dairy Products Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Coffee Machine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)